Ulangkaya, Hasheer .
HRN: 23-17-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2023
MUPIROCIN 2%, 15G (TUBE)
11/02/2023
11/08/2023
TOPICAL
Ample Amount
BID
Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes